Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Syria gets donation of 150,000 COVID shots from China

Published 04/24/2021, 09:46 AM
Updated 04/24/2021, 09:51 AM
© Reuters. A batch of China's Sinopharm COVID-19 vaccine arrives in Damascus

DAMASCUS (Reuters) - A donation by China of 150,000 doses of its Sinopharm COVID-19 vaccine arrived in Damascus on Saturday, with another batch of the same size planned, Syrian officials said.

"We appreciate this aid which will allow the health ministry to combat the pandemic, to curb its impact on health, society and the economy," the health minister, Hassan Ghabash, told reporters at the airport.

He said the shots would go first to healthcare workers, and then to the elderly and people with chronic diseases.

The Chinese ambassador to Syria said the next 150,000 doses would arrive soon.

Officials have said the country is also discussing vaccines with Russia, Syrian President Bashar al-Assad's key ally, but no announcements have been made over receiving shots from Moscow.

Damascus this week got its first delivery of COVID-19 vaccines from the global COVAX initiative, nearly 200,000 AstraZeneca (NASDAQ:AZN) shots, U.N officials said. More deliveries are expected in coming weeks.

The World Health Organization has deployed teams across Syria for a vaccination programme that will be rolled out both in government territory and some parts of the country outside state control after ten years of war.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.